Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage

Overview

Journal Anticancer Agents Med Chem

Publisher Bentham Science Publishers

Specialties Chemistry
Oncology

Date 2024 Feb 20

PMID 38375808

Authors

Ning Fan

Lixiu Zhang

Zhiping Wang

Hui Ding

Zhongjin Yue

Affiliations

Soon will be listed here.

Abstract

Background: Bladder cancer is the most common malignant tumor of the urinary system. Nevertheless, current therapies do not provide satisfactory results. It is imperative that novel strategies should be developed for treating bladder cancer.

Objectives: To evaluate the effect of a broad-spectrum anti-parasitic agent, Ivermectin, on bladder cancer cells and .

Methods: CCK-8 and EdU incorporation assays were used to evaluate cell proliferation. Apoptosis was detected by flow cytometry, TUNEL assay, and western blotting. Flow cytometry and DCFH-DA assay were used to analyze the reactive oxygen species (ROS) levels. DNA damage was determined by Neutral COMET assay and γ H2AX expression. Proteins related to apoptosis and DNA damage pathways were determined by WB assay. Xenograft tumor models in nude mice were used to investigate the anti-cancer effect of Ivermectin .

Results: Our study showed that and , Ivermectin inhibited the growth of bladder cancer cells. In addition, Ivermectin could induce apoptosis, ROS production, DNA damage, and activate ATM/P53 pathwayrelated proteins in bladder cancer cells.

Conclusions: According to these findings, Ivermectin may be a potential therapeutic candidate against bladder cancer due to its significant anti-cancer effect.

Citing Articles

Cytotoxic effects of ivermectin on : induction of apoptosis and cell cycle arrest.

Barzola F, Laiolo J, Cotelo C, Joray M, Volpini X, Rivero M Front Microbiol. 2024; 15:1484805.

PMID: 39545240 PMC: 11560887. DOI: 10.3389/fmicb.2024.1484805.

References

Kamat A, Hahn N, Efstathiou J, Lerner S, Malmstrom P, Choi W . Bladder cancer. Lancet. 2016; 388(10061):2796-2810. DOI: 10.1016/S0140-6736(16)30512-8. View

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

Tan W, Tan W, Tan M, Khetrapal P, Dong L, deWinter P . Novel urinary biomarkers for the detection of bladder cancer: A systematic review. Cancer Treat Rev. 2018; 69:39-52. DOI: 10.1016/j.ctrv.2018.05.012. View

Abufaraj M, Dalbagni G, Daneshmand S, Horenblas S, Kamat A, Kanzaki R . The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review. Eur Urol. 2017; 73(4):543-557. PMC: 8177016. DOI: 10.1016/j.eururo.2017.09.030. View

Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F . Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2016; 71(1):96-108. DOI: 10.1016/j.eururo.2016.06.010. View

Rizzo A, Mollica V, Massari F . Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systematic Review and Meta-analysis. Eur Urol Focus. 2021; 8(1):152-159. DOI: 10.1016/j.euf.2021.01.003. View

Pushpakom S, Iorio F, Eyers P, Jane Escott K, Hopper S, Wells A . Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018; 18(1):41-58. DOI: 10.1038/nrd.2018.168. View

Jourdan J, Bureau R, Rochais C, Dallemagne P . Drug repositioning: a brief overview. J Pharm Pharmacol. 2020; 72(9):1145-1151. PMC: 7262062. DOI: 10.1111/jphp.13273. View

Crump A, Omura S . Ivermectin, 'wonder drug' from Japan: the human use perspective. Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87(2):13-28. PMC: 3043740. DOI: 10.2183/pjab.87.13. View

10.

Molyneux D, Ward S . Reflections on the Nobel Prize for Medicine 2015--The Public Health Legacy and Impact of Avermectin and Artemisinin. Trends Parasitol. 2015; 31(12):605-607. DOI: 10.1016/j.pt.2015.10.008. View

11.

Dou Q, Chen H, Wang K, Yuan K, Lei Y, Li K . Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer. Cancer Res. 2016; 76(15):4457-69. DOI: 10.1158/0008-5472.CAN-15-2887. View

12.

Liu Y, Fang S, Sun Q, Liu B . Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress. Biochem Biophys Res Commun. 2016; 480(3):415-421. DOI: 10.1016/j.bbrc.2016.10.064. View

13.

Sharmeen S, Skrtic M, Sukhai M, Hurren R, Gronda M, Wang X . The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. Blood. 2010; 116(18):3593-603. DOI: 10.1182/blood-2010-01-262675. View

14.

Hashimoto H, Messerli S, Sudo T, Maruta H . Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines. Drug Discov Ther. 2012; 3(6):243-6. View

15.

Zhang P, Zhang Y, Liu K, Liu B, Xu W, Gao J . Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway. Cell Prolif. 2018; 52(2):e12543. PMC: 6496724. DOI: 10.1111/cpr.12543. View

16.

Nambara S, Masuda T, Nishio M, Kuramitsu S, Tobo T, Ogawa Y . Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer. Oncotarget. 2018; 8(64):107666-107677. PMC: 5746098. DOI: 10.18632/oncotarget.22587. View

17.

Melotti A, Mas C, Kuciak M, Lorente-Trigos A, Borges I, Ruiz i Altaba A . The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. EMBO Mol Med. 2014; 6(10):1263-78. PMC: 4287931. DOI: 10.15252/emmm.201404084. View

18.

Liu J, Zhang K, Cheng L, Zhu H, Xu T . Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin. Drug Des Devel Ther. 2020; 14:285-296. PMC: 6982461. DOI: 10.2147/DDDT.S237393. View

19.

Schieber M, Chandel N . ROS function in redox signaling and oxidative stress. Curr Biol. 2014; 24(10):R453-62. PMC: 4055301. DOI: 10.1016/j.cub.2014.03.034. View

20.

Dhuppar S, Roy S, Mazumder A . γH2AX in the S Phase after UV Irradiation Corresponds to DNA Replication and Does Not Report on the Extent of DNA Damage. Mol Cell Biol. 2020; 40(20). PMC: 7523655. DOI: 10.1128/MCB.00328-20. View